Revvity Health Sciences Inc Revvity Health Sciences Cas9-gRNA Mito Depletion Enzyme, Human, CRISPR-Cas9 Module

Supplier:  Revvity Health Sciences Inc NOVA803500

The NEXTFLEX Cas9-gRNA Mito Depletion Enzyme (Human) is a flexible CRISPR-Cas9 module that removes mitochondrial DNA from human NGS libraries. It integrates at the double-stranded DNA stage of various workflows, directing more reads to nuclear genes and regulatory elements by reducing mitochondrial background.

• Removes mitochondrial DNA sequences from human NGS libraries.
• Integrates directly into existing ATAC-seq, DNA-seq, bulk RNA-seq, or single-cell workflows.
• Directs more sequencing reads to nuclear genes, regulatory elements, and other loci of interest.
• Supplied as a pre-complexed Cas9–guide RNA mixture.
• Contains 657 guide RNAs targeting 17 mtDNA-encoded genes and nuclear pseudogenes.
• Compatible with diverse human library types and sequencing platforms.

Catalog No. NC3998894